Načítá se...
Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy
CD8(+) T cells in progressing tumors frequently fail to mount an effective antitumor response often in association with the expression of inhibitory receptors, including programmed cell death-1 (PD-1) and lymphocyte-activation gene 3 (Lag3). Using a lymphoma tumor model, we demonstrate that tumor-in...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Landes Bioscience
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4002624/ https://ncbi.nlm.nih.gov/pubmed/24790793 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.27680 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|